Neurobio.ai

NeuroBio is an AI-driven biotechnology company focused on discovering and developing novel therapeutics for neurodegenerative and psychiatric disorders. The company utilizes its proprietary NeuroAI™ platform, which employs artificial neural networks (ANNs) to analyze complex biological data, identify novel drug targets, and repurpose existing medicines. NeuroBio's primary research focuses on Alzheimer's disease and Post-Traumatic Stress Disorder (PTSD), leveraging expertise in human genetics, immunology, and clinical neurology. By combining advanced machine learning with innovative science, the company aims to precision-engineer treatments with a higher probability of clinical success. NeuroBio also explores applications in oncology, dermatology, and other disease areas through its AI-guided discovery engine.